Petição de recurso
#12.2
Recurso: Petição 870260016373, de 23/02/2026
03/03/2026
RPI 2878
Application data
Number
112020008214Type
Filing
Publication
PCT
US2018058194 The application is under appeal: the INPI has yet to review the decision.
Latest action published by the INPI: 03/03/2026. We update with every new RPI gazette, published weekly.
Applicants
CURIS, INC.
US
Inventors
R. B. (pessoa física)
US
IPC Classification
Priority claims
US
62/579.502 · 10/31/2017
Abstract
A presente invenção fornece métodos de tratamento de distúrbios hematológicos e tumores malignos sólidos, utilizando compostos de indazol substituídos e sais farmaceuticamente aceitáveis destes. Os compostos inibem as quinases IRAK4 e BCL-2.
Publications in the Brazilian Industrial Property Gazette (RPI).
#12.2
Recurso: Petição 870260016373, de 23/02/2026
03/03/2026
RPI 2878
#9.2
12/23/2025
RPI 2868
#7.1
08/05/2025
RPI 2848
#6.23
07/26/2022
RPI 2690
#15.35
12/07/2021
RPI 2657
#1.3
10/27/2020
RPI 2599
#1.1
10/06/2020
RPI 2596
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.